Everything SD

Merck Bet $9.2 Billion on a San Diego Flu Drug—Here's Why

Cidara Therapeutics’ experimental drug cut flu risk by 76 percent in a trial. Now researchers are testing whether it can protect the most vulnerable.

Read article